• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的选择性嗅觉减退和黑质纹状体多巴胺能神经支配缺失

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

作者信息

Bohnen Nicolaas I, Gedela Satyanarayana, Kuwabara Hiroto, Constantine Gregory M, Mathis Chester A, Studenski Stephanie A, Moore Robert Y

机构信息

Dept. of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

J Neurol. 2007 Jan;254(1):84-90. doi: 10.1007/s00415-006-0284-y. Epub 2007 Feb 14.

DOI:10.1007/s00415-006-0284-y
PMID:17508142
Abstract

Olfactory dysfunction is a frequent and early feature of Parkinson's disease (PD), often preceding the motor symptoms by several years. Assessment of olfactory deficits may be used in the diagnostic assessment of PD. In this study we investigated the relationship between selective deficits in smell identification and nigrostriatal dopaminergic denervation in patients with PD. Twenty-seven PD patients (Hoehn and Yahr stages I-III) and 27 healthy controls matched for gender and age underwent olfactory testing using the 40-odor University of Pennsylvania Smell Identification Test (UPSIT). PD patients underwent (11)C-beta-CFT dopamine transporter (DAT) positron emission tomography (PET) imaging and clinical motor examination. We found that total UPSIT scores were significantly lower in the PD than in the control subjects (z=4.7, p<0.0001). Analysis of the individual smell scores identified 3 odors with an accuracy of >0.75 for the diagnosis of PD. These odors were banana, licorice, and dill pickle. A PD-specific smell identification score (UPSIT-3) was calculated for these 3 odors. Analysis of the patient PET data demonstrated significant correlations between dorsal striatal DAT activity and the UPSIT-3 (R(S)=0.53, p=0.0027) and total UPSIT (R(S)=0.44, p=0.023) scores. UPSIT-3 (R(S)=0.43, p=0.027) but not total UPSIT (R(S)=0.20, ns) correlated with nigral DAT activity. We conclude that patients with PD have selective hyposmia. A simplified UPSIT smell identification test consisting of 3 PD-selective odors had more robust correlation with nigral and dorsal striatial dopaminergic activity compared with the full UPSIT scores in patients with PD. Assessment of selective olfactory deficits may be used as a simplified olfactory screening test in the evaluation of subjects with possible PD.

摘要

嗅觉功能障碍是帕金森病(PD)常见的早期特征,通常在运动症状出现前数年就已存在。嗅觉缺陷评估可用于PD的诊断评估。在本研究中,我们调查了PD患者嗅觉识别选择性缺陷与黑质纹状体多巴胺能去神经支配之间的关系。27例PD患者(霍恩和雅尔分期I - III期)和27名年龄及性别匹配的健康对照者接受了使用40种气味的宾夕法尼亚大学嗅觉识别测试(UPSIT)进行的嗅觉测试。PD患者接受了(11)C-β-CFT多巴胺转运体(DAT)正电子发射断层扫描(PET)成像及临床运动检查。我们发现,PD患者的UPSIT总分显著低于对照组(z = 4.7,p < 0.0001)。对个体嗅觉分数的分析确定了3种气味,其诊断PD的准确率> 0.75。这些气味是香蕉、甘草和莳萝泡菜。针对这3种气味计算了一个PD特异性嗅觉识别分数(UPSIT - 3)。对患者PET数据的分析表明,背侧纹状体DAT活性与UPSIT - 3(R(S)=0.53,p = 0.0027)及UPSIT总分(R(S)=0.44,p = 0.023)之间存在显著相关性。UPSIT - 3(R(S)=0.43,p = 0.027)与黑质DAT活性相关,而UPSIT总分(R(S)=0.20,无统计学意义)与黑质DAT活性不相关。我们得出结论,PD患者存在选择性嗅觉减退。与PD患者的完整UPSIT分数相比,由3种PD选择性气味组成的简化UPSIT嗅觉识别测试与黑质和背侧纹状体多巴胺能活性的相关性更强。选择性嗅觉缺陷评估可作为一种简化的嗅觉筛查测试,用于评估可能患有PD的受试者。

相似文献

1
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.帕金森病中的选择性嗅觉减退和黑质纹状体多巴胺能神经支配缺失
J Neurol. 2007 Jan;254(1):84-90. doi: 10.1007/s00415-006-0284-y. Epub 2007 Feb 14.
2
Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.帕金森病中的选择性嗅觉减退:与海马多巴胺活性的关联。
Neurosci Lett. 2008 Dec 5;447(1):12-6. doi: 10.1016/j.neulet.2008.09.070. Epub 2008 Sep 30.
3
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity.帕金森病患者阿尔茨海默病选择性气味识别测试的表现及其与脑多巴胺转运体活性的关系。
Parkinsonism Relat Disord. 2009 Nov;15(9):640-3. doi: 10.1016/j.parkreldis.2009.03.004. Epub 2009 Mar 28.
4
Olfactory loss and nigrostriatal dopaminergic denervation in the elderly.老年人的嗅觉丧失和黑质纹状体多巴胺能神经纤维丧失。
Neurosci Lett. 2010 Nov 5;484(3):163-7. doi: 10.1016/j.neulet.2010.08.037. Epub 2010 Aug 19.
5
Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.帕金森病中多巴胺能末梢功能障碍与基底节和嗅束的微观结构异常的相关性。
Brain. 2013 Oct;136(Pt 10):3028-37. doi: 10.1093/brain/awt234. Epub 2013 Sep 6.
6
Application of the University Of Pennsylvania Smell Identification Test (traditional Chinese version) for detecting olfactory deficits in early Parkinson's disease in a Taiwanese cohort.应用宾夕法尼亚大学嗅觉识别测试(繁体中文版)检测台湾人群早期帕金森病的嗅觉缺陷。
J Parkinsons Dis. 2014;4(2):175-80. doi: 10.3233/JPD-130309.
7
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.[99mTc]TRODAT-1单光子发射计算机断层扫描成像与早期帕金森病的嗅觉识别相关。
Neurology. 2005 May 24;64(10):1716-20. doi: 10.1212/01.WNL.0000161874.52302.5D.
8
Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation.伴有黑质纹状体去神经支配影像学证据的帕金森病患者嗅觉识别受损的患病率。
J Neural Transm (Vienna). 2016 Apr;123(4):421-4. doi: 10.1007/s00702-016-1524-7. Epub 2016 Feb 24.
9
Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.早期帕金森病在前嗅结构而非黑质中存在偏侧化微观结构变化。
J Neurol. 2017 Jul;264(7):1497-1505. doi: 10.1007/s00415-017-8555-3. Epub 2017 Jun 26.
10
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.帕金森病嗅觉功能障碍的运动和非运动相关性。
J Neurol Sci. 2011 Nov 15;310(1-2):21-4. doi: 10.1016/j.jns.2011.06.020. Epub 2011 Jun 25.

引用本文的文献

1
Imaging advances to detect non-motor prodromal markers of Parkinson's disease and explore therapeutic translation opportunities.成像技术的进展用于检测帕金森病的非运动前驱标志物并探索治疗转化机会。
NPJ Parkinsons Dis. 2025 Jun 18;11(1):174. doi: 10.1038/s41531-025-01004-0.
2
Alpha-synuclein pathology and Parkinson's disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches.α-突触核蛋白病理学与帕金森病相关嗅觉功能障碍:临床前模型与治疗方法的最新进展
Mamm Genome. 2025 Apr 28. doi: 10.1007/s00335-025-10128-w.
3
Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.

本文引用的文献

1
Early detection of probable idiopathic Parkinson's disease: I. development of a diagnostic test battery.疑似特发性帕金森病的早期检测:I. 一套诊断测试方法的开发
Mov Disord. 2000 May;15(3):467-473. doi: 10.1002/1531-8257(200005)15:3<467::AID-MDS1007>3.0.CO;2-#.
2
Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb.纹状体去传入增加成年嗅球中的多巴胺能神经发生。
Exp Neurol. 2006 Jan;197(1):113-21. doi: 10.1016/j.expneurol.2005.08.028. Epub 2005 Oct 24.
3
The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.
利用多个队列、机器学习和项目反应理论开发一种简化嗅觉测试以识别帕金森病。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):85. doi: 10.1038/s41531-025-00904-5.
4
Hyposmia in Parkinson's disease; exploring selective odour loss.帕金森病中的嗅觉减退;探索选择性气味丧失。
NPJ Parkinsons Dis. 2025 Apr 4;11(1):67. doi: 10.1038/s41531-025-00922-3.
5
Intranasal iron administration induces iron deposition, immunoactivation, and cell-specific vulnerability in the olfactory bulb of C57BL/6 mice.经鼻给予铁会在C57BL/6小鼠的嗅球中诱导铁沉积、免疫激活和细胞特异性易损性。
Zool Res. 2025 Jan 18;46(1):209-224. doi: 10.24272/j.issn.2095-8137.2024.240.
6
Olfactory Dysfunction in Parkinson's Disease, Its Functional and Neuroanatomical Correlates.帕金森病中的嗅觉功能障碍及其功能和神经解剖学关联
NeuroSci. 2023 Jun 5;4(2):134-151. doi: 10.3390/neurosci4020013. eCollection 2023 Jun.
7
Unraveling olfactory subtypes in Parkinson's disease and their effect on the natural history of the disease.解析帕金森病中的嗅觉亚型及其对疾病自然史的影响。
J Neurol. 2024 Sep;271(9):6102-6113. doi: 10.1007/s00415-024-12586-9. Epub 2024 Jul 24.
8
The Olfactory Trail of Neurodegenerative Diseases.神经退行性疾病的嗅觉轨迹。
Cells. 2024 Apr 2;13(7):615. doi: 10.3390/cells13070615.
9
Synthesis of Novel Plant-Derived Encapsulated Radiolabeled Compounds for the Diagnosis of Parkinson's Disease and the Evaluation of Biological Effects with In Vitro/In Vivo Methods.新型植物源性包封放射性化合物的合成及其在体外/体内方法评估帕金森病的生物学效应和诊断中的应用。
Mol Neurobiol. 2024 Nov;61(11):8851-8871. doi: 10.1007/s12035-024-04103-w. Epub 2024 Apr 3.
10
Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis.帕金森病患者的嗅觉功能障碍:一项系统评价和荟萃分析。
Curr J Neurol. 2023 Oct 7;22(4):249-254. doi: 10.18502/cjn.v22i4.14530.
帕金森病的非运动症状复合体:全面评估至关重要。
Curr Neurol Neurosci Rep. 2005 Jul;5(4):275-83. doi: 10.1007/s11910-005-0072-6.
4
Neuronal fate determinants of adult olfactory bulb neurogenesis.成体嗅球神经发生的神经元命运决定因素。
Nat Neurosci. 2005 Jul;8(7):865-72. doi: 10.1038/nn1479.
5
Functional magnetic resonance imaging study of human olfaction and normal aging.人类嗅觉与正常衰老的功能磁共振成像研究
J Gerontol A Biol Sci Med Sci. 2005 Apr;60(4):510-4. doi: 10.1093/gerona/60.4.510.
6
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.[99mTc]TRODAT-1单光子发射计算机断层扫描成像与早期帕金森病的嗅觉识别相关。
Neurology. 2005 May 24;64(10):1716-20. doi: 10.1212/01.WNL.0000161874.52302.5D.
7
Stages in the development of Parkinson's disease-related pathology.帕金森病相关病理学的发展阶段。
Cell Tissue Res. 2004 Oct;318(1):121-34. doi: 10.1007/s00441-004-0956-9. Epub 2004 Aug 24.
8
Idiopathic hyposmia as a preclinical sign of Parkinson's disease.特发性嗅觉减退作为帕金森病的临床前体征
Ann Neurol. 2004 Aug;56(2):173-81. doi: 10.1002/ana.20160.
9
The preclinical detection of Parkinson's disease: ready for prime time?帕金森病的临床前检测:准备好进入黄金时期了吗?
Ann Neurol. 2004 Aug;56(2):169-71. doi: 10.1002/ana.20180.
10
Olfaction and Parkinson's syndromes: its role in differential diagnosis.嗅觉与帕金森综合征:其在鉴别诊断中的作用。
Curr Opin Neurol. 2004 Aug;17(4):417-23. doi: 10.1097/01.wco.0000137531.76491.c2.